Investor Alert

May 11, 2022, 4:33 p.m. EDT

SPDR S&P Biotech ETF closed Monday at a five-year low

The SPDR S&P Biotech ETF (PSE:XBI) closed at a five-year low of $64.37 on Monday as U.S. stocks plunged on concerns about continued inflation and the threat of weaker growth. The last time the price for the biotech ETF was down this low was in December 2018. "A combination of clinical and regulatory setbacks, lack of M&A, and macro environment has created a downward spiral that appears to us to be an excessive overreaction to the 2020- to early-'21 'bubble,'" RBC Capital Markets analyst Brian Abrahams told investors on Tuesday. The SPDR S&P Biotech ETF has tumbled 37.3% this year, while the broader S&P 500 (S&P:SPX) is down 16.2%.

Link to MarketWatch's Slice.